Results 41 to 50 of about 7,946 (150)

Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study

open access: yesBMC Medicine, 2020
Background Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited.
Duong Thuy Tran   +7 more
doaj   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Varenicline in the treatment of tobacco dependence

open access: yesNeuropsychiatric Disease and Treatment, 2008
Karl Fagerström1, John Hughes21Smokers Information Centre, Fagerström Consulting AB, Berga Alle 1, 25452 Helsingborg, Sweden; 2University of Vermont, Burlington, Vermont, USAAbstract: Varenicline, a partial agonist of α4& ...
Karl Fagerström, John Hughes
doaj  

An integrated behavioral change model for smoking cessation in periodontal care: The four‐stage behavioral support staircase

open access: yesPeriodontology 2000, EarlyView.
Abstract Objectives Smoking tobacco is a critical modifiable risk factor for periodontal and peri‐implant diseases. This narrative review integrates established behavioral theories with communication‐based psychological processes to propose an evidence‐based model for smoking cessation support in periodontal care.
Christoph A. Ramseier
wiley   +1 more source

Identifying determinants of varenicline adherence using the Theoretical Domains framework: a rapid review

open access: yesBMC Public Health
Background Adhering to varenicline has been shown to significantly improve the chances of successfully quitting smoking, with studies indicating a twofold increase in 6-month quit rates.
Nadia Minian   +9 more
doaj   +1 more source

Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map

open access: yesAddiction, Volume 121, Issue 8, Page 1957-1971, August 2026.
Abstract Background and aims Electronic cigarettes (EC) are considered a smoking cessation tool in some countries, such as the United Kingdom, but uncertainty remains internationally over whether their benefits outweigh potential harms when used for this purpose.
Angela Difeng Wu   +13 more
wiley   +1 more source

Study on effect of 5A intervention method combined with varenicline for smoking cessation of COPD patients in stable stage

open access: yesHuli yanjiu, 2015
Objective:To study the effect of 5Aintervention method combined with varenicline for smoking cessation of COPD patients in stable stage.Methods:A total of 300 cases of COPD patients were randomly divided into 5Asmoking cessation group,varenicline group ...
洪涵涵, 王伟, 陈丽调
doaj  

Discrimination experiences are associated with same‐day and next‐day smoking among adults with low socio‐economic status trying to quit: A secondary analysis of data from a randomized clinical trial

open access: yesAddiction, Volume 121, Issue 8, Page 2197-2209, August 2026.
Abstract Background and aims Research indicates that experiencing discrimination may be associated with a return to smoking following a quit attempt. The current study aimed to characterize day‐to‐day relations between discrimination and smoking in the context of a smoking cessation trial for adults with socio‐economic disadvantage.
Laili K. Boozary   +10 more
wiley   +1 more source

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation

open access: yesHealth Technology Assessment, 2014
Background: Tobacco smoking is one of the leading causes of deaths worldwide. Nearly one-fifth of adults in the UK regularly smoke cigarettes. The ill-health associated with smoking costs the NHS over £3B every year.
Joanna Leaviss   +7 more
doaj   +1 more source

Research on the Mechanism of Natural Products Acting on Chronic Obstructive Pulmonary Disease

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
This figure illustrates that approximately 80 natural compounds exert therapeutic effects against chronic obstructive pulmonary disease by targeting pathological mechanisms such as airway inflammation, oxidative stress, airway remodeling, mucus hypersecretion, emphysema, protease–antiprotease imbalance, apoptosis, and autophagy.
Shuna Wei, Xiaoju Liu
wiley   +1 more source

Home - About - Disclaimer - Privacy